Mongay L, Plaza S, Vigorito E, Serra-Pagès C, Vives J
Servei d'Immunologia, Hospital Clínic i Provincial de Barcelona, Villarroel 170, Barcelona 08036, Spain.
J Biol Chem. 2001 Jul 6;276(27):25030-6. doi: 10.1074/jbc.M102184200. Epub 2001 May 10.
In mammalian cells, CDK2 is part of a multiprotein complex that includes Cyclin A or E and cell cycle regulatory proteins such as p21(Cip1), PCNA, p27(Kip1), p45(SKP2), p19(SKP1), and CksHs1/CksHs2. While the role of some of these proteins has been well studied, the function of other proteins in the complex remains unclear. In this study, we showed that the carboxyl-terminal region of p45(SKP2) associates directly with CksHs1 and that CksHs1 negatively regulated the interaction between p45(SKP2) and CDK2. Moreover, we showed that overexpression of CksHs1 inhibits CDK2 kinase activity and that additional expression of p45(SKP2) overcame this inhibition and restored CDK2 kinase activity. We proposed that the association of CksHs1 and p45(SKP2) prevented CksHs1 from binding CDK2 and negatively regulating the CDK2 kinase activity.
在哺乳动物细胞中,CDK2是一种多蛋白复合物的一部分,该复合物包括细胞周期蛋白A或E以及细胞周期调节蛋白,如p21(Cip1)、增殖细胞核抗原(PCNA)、p27(Kip1)、p45(SKP2)、p19(SKP1)和CksHs1/CksHs2。虽然其中一些蛋白质的作用已得到充分研究,但该复合物中其他蛋白质的功能仍不清楚。在本研究中,我们表明p45(SKP2)的羧基末端区域直接与CksHs1结合,并且CksHs1负向调节p45(SKP2)与CDK2之间的相互作用。此外,我们表明CksHs1的过表达抑制CDK2激酶活性,并且p45(SKP2)的额外表达克服了这种抑制并恢复了CDK2激酶活性。我们提出,CksHs1与p45(SKP2)的结合阻止了CksHs1与CDK2结合并负向调节CDK2激酶活性。